MIRA INFORM REPORT

 

 

Report No. :

349883

Report Date :

10.11.2015

 

IDENTIFICATION DETAILS

 

Name :

EUROVAN NV

 

 

Registered Office :

Stevoortse  Kiezel  6-Bus  2, 3511 Hasselt

 

 

Country :

Belgium

 

 

Financials (as on) :

31.12.2014

 

 

Date of Incorporation :

10.05.1993

 

 

Com. Reg. No.:

450053868

 

 

Legal Form :

Public Limited Company

 

 

Line of Business :

Manufacture of Basic Pharmaceutical Products.

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

 

Status :

Moderate

Payment Behaviour :

Slow

Litigation :

Clear

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

Belarus

B2

B2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


 

BELARUS - ECONOMIC OVERVIEW

 

As part of the former Soviet Union, Belarus had a relatively well-developed, though aging industrial base; it retained this industrial base - which is now outdated, energy inefficient, and dependent on subsidized Russian energy and preferential access to Russian markets - following the breakup of the USSR. The country also has a broad agricultural base which is largely inefficient and dependent on government subsidies. After an initial burst of capitalist reform from 1991-94, including privatization of smaller state enterprises and some service sector businesses, creation of institutions of private property, and development of entrepreneurship, Belarus' economic development greatly slowed. About 80% of all industry remains in state hands, and foreign investment has been hindered by a climate hostile to business. A few banks, which had been privatized after independence, were renationalized. State banks account for 75% of the banking sector. Economic output, which had declined for several years following the collapse of the Soviet Union, revived in the mid-2000s thanks to the boom in oil prices. Belarus has only small reserves of crude oil, though it imports most of its crude oil and natural gas from Russia at prices substantially below the world market. Belarus exported refined oil products at market prices produced from Russian crude oil purchased at a steep discount. In late 2006, Russia began a process of rolling back its subsidies on oil and gas to Belarus. Tensions over Russian energy reached a peak in 2010, when Russia stopped the export of all subsidized oil to Belarus save for domestic needs. In December 2010, Russia and Belarus reached a deal to restart the export of discounted oil to Belarus. In 2015, Belarus continued to import Russian crude oil at a discounted price. However, the plunge in global oil prices heavily reduced revenues. Little new foreign investment has occurred in recent years. In 2011, a financial crisis began, triggered by government directed salary hikes unsupported by commensurate productivity increases. The crisis was compounded by an increased cost in Russian energy inputs and an overvalued Belarusian ruble, and eventually led to a near three-fold devaluation of the Belarusian ruble in 2011. In November 2011, Belarus agreed to sell to Russia its remaining shares in Beltransgaz, the Belarusian natural gas pipeline operator, in exchange for reduced prices for Russian natural gas. Receiving more than half of a $3 billion loan from the Russian-dominated Eurasian Economic Community (EurAsEC) Bail-out Fund, a $1 billion loan from the Russian state-owned bank Sberbank, and the $2.5 billion sale of Beltranzgas to Russian state-owned Gazprom helped stabilize the situation in 2012; nevertheless, the Belarusian currency lost more than 60% of its value, as the rate of inflation reached new highs in 2011 and 2012, before calming in 2013. As of January 2014, the final tranche of the EurAsEC loan has been delayed. In December 2013, Russia announced a new loan for Belarus of up to $2 billion for 2014. Notwithstanding foreign assistance, the Belarusian economy continued to struggle under the weight of high external debt servicing payments and trade deficit. In mid-December 2014, structural economic shortcomings were aggravated by the devaluation of the Russian ruble and triggered a near 40% devaluation of the Belarusian ruble. Belarus entered 2015 with stagnant economic growth and reduced hard currency reserves, with under one month of import cover.

 

Source : CIA


Company summary

 

Business  Number

450053868

Branche  Unit  Number

2066653096

Company  name

EUROVAN  NV

Address

Stevoortse  Kiezel  6-Bus  2, 3511 Hasselt

Number  of  staff

-

Date  of  establishment

10/05/1993

Telephone  number

-

Fax  number

-

 

 

Commentary

 

The business was established over 22 years ago.

No employees are recorded for this business.

The business has been at the address for over 22 years.

Net Worth decreased by 22% during the latest trading period.

The business saw a decrease in their Cash Balance of 42% during the latest trading period.

Working Capital is a negative amount during the latest trading period.

 

 

ACCOUNTS

 

DATE  OF  LATEST  ACCOUNTS

TURNOVER

PROFIT  BEFORE  TAX

NET  WORTH

WORKING  CAPITAL

31/12/2014

--

-2,218

7,806

-4,593

31/12/2013

--

-2,788

10,024

-4,910

31/12/2012

--

-2,939

12,812

-4,658

 

--

 

 

 

ACCOUNTS

 

 

 

 

 

DATE  OF  LATEST  ACCOUNTS

BALANCE  TOTAL

NUMBER  OF  EMPLOYEES

CAPITAL

CASHFLOW

31/12/2014

12,644

-

62,000

318

31/12/2013

15,357

-

62,000

-252

31/12/2012

18,445

-

62,000

-404

 

 

Payment expectations

 

Past  payments

 

Payment  expectation  days

--

Industry  average  payment

55.53

Industry  average  day  sales

94.13

expectation  days

 

outstanding

 

Day  sales  outstanding

--

 

 

 

 

Court data summary

 

BANKRUPTCY DETAILS

Court action type                       No

 

PROTESTED BILLS

Bill amount                                -

 

NSSO DETAILS

Date of summons                    

 

 

Company information

 

Business  Number

450053868

Company  Name

EUROVAN  NV

Fax  Number

-

Date  Founded

10/05/1993

Company  status

active

Company  Type

Public Limited Company

Currency

Euro  (€)

Date  of  Latest  Accounts

31/12/2014

Activity  Code

21100

Liable  for  VAT

no

Activity  Description

Manufacture  of  basic pharmaceutical products

Belgian Bullettin of Acts Publications

Moniteur Belge

 

Contractor details

 

Registered  contractor number

-

Contractor  description

-

Date  struck  off  register

 

 

PERSONNEL  (NSSO  CLASSIFICATION)

 

Code

-

Description

-

 

 

 

SIGNIFICANT  EVENTS

 

Event  Date

09/11/2012

Event  Description

--

Event  Details

Omzetting aandelen aan toonder in aandelen op naam.

 

 


Company accounts

 

ASSETS

 

 

 

 

 

 

 

 

 

 

Annual  accounts

31-12-2014

%

31-12-2013

%

31-12-2012

%

31-12-2011

%

31-12-2010

Weeks

52

 

52

 

52

 

52

 

52

Currency

EUR

 

EUR

 

EUR

 

EUR

 

EUR

Total  fixed  assets

12,399

-16.98

14,934

-14.52

17,470

-12.67

20,005

-11.25

22,541

Intangible  fixed  assets

0

-

0

-

0

-

0

-

0

Tangible  fixed  assets

12,399

-16.98

14,934

-14.52

17,470

-12.67

20,005

-11.25

22,541

Land  &  building

12,399

-10.71

13,886

-9.67

15,373

-8.82

16,861

-8.11

18,348

Plant  &  machinery

0

-100

1,048

-50.01

2,096

-33.33

3,145

-25.00

4,193

Furniture  &  Vehicles

0

-

0

-

0

-

0

-

0

Leasing  &  Other  Similar  Rights

0

-

0

-

0

-

0

-

0

Other  tangible  assets

0

-

0

-

0

-

0

-

0

Financial  fixed  assets

0

-

0

-

0

-

0

-

0

Total  current  assets

245

-42.04

423

-56.63

975

182

345

11.14

311

Inventories

0

-

0

-

0

-

0

-

0

Raw  materials  &  consumables

0

-

0

-

0

-

0

-

0

Work  in  progress

0

-

0

-

0

-

0

-

0

Finished  goods

0

-

0

-

0

-

0

-

0

Other  stocks

0

-

0

-

0

-

0

-

0

Trade  debtors

0

-

0

-100

600

-

0

-

0

Other  amounts  receivable

0

-

0

-

0

-

0

-

0

Cash

245

-42.04

423

12.71

375

8.75

345

11.14

311

Miscellaneous  current  assets

0

-

0

-

0

-

0

-

0

Total  Assets

12,644

-17.67

15,357

-16.74

18,445

-9.36

20,351

-10.94

22,852

LIABILITIES

 

 

 

 

 

 

 

 

 

 

Total shareholder equity

7,806

-22.13

10,024

-21.76

12,812

-18.66

15,751

-21.42

20,045

Issued  share  capital

62,000

0

62,000

0

62,000

0

62,000

0

62,000

Share  premium  account

0

-

0

-

0

-

0

-

0

Revaluation  reserve

0

-

0

-

0

-

0

-

0

Reserves

-54,194

-4.27

-51,976

-5.67

-49,188

-6.35

-46,249

-10.23

-41,955

Provisions  for  Liabilities  &  Charges

0

-

0

-

0

-

0

-

0

Deffered  taxes

0

-

0

-

0

-

0

-

0

Creditors

4,838

-9.28

5,333

-5.33

5,633

22.47

4,599

63.88

2,807

Other  long  term  loans

0

-

0

-

0

-

0

-

0

Long  term  group  loans

-

-

-

-

-

-

-

-

-

Other  long  term  liabilities

0

-

0

-

0

-

0

-

0

Total  long  term  debts

0

-

0

-

0

-

0

-

0

Current  portion  of  long  term  debt

0

-

0

-

0

-

0

-

0

Financial  debts

0

-

0

-

0

-

0

-

0

Trade  creditors

0

-

0

-

0

-

0

-100

998

Amounts  Payable  for  Taxes,  Remuneration  &  Social Security

0

-

0

-

0

-

0

-

0

Miscellaneous  current  liabilities

4,838

-9.28

5,333

-5.33

5,633

22.47

4,599

154

1,808

Total  current  liabilities

4,838

-9.28

5,333

-5.33

5,633

22.47

4,599

63.88

2,807

Total  Liabilities

12,644

-17.67

15,357

-16.74

18,445

-9.36

20,351

-10.94

22,852

 

RATIO  ANALYSIS

 

 

 

 

 

 

 

 

 

 

TRADING  PERFORMANCE

 

 

 

 

 

 

 

 

 

Profit  Before  Tax

-

-

-

-

-

-

-

-

-

Return  on  capital  employed

-28.41

-2.16

-27.81

-21.23

-22.94

84.15

-27.26

-307

-6.69

Return  on  total  assets  employed

-17.54

96.64

-18.15

-13.94

-15.93

75.50

-21.10

-259

-5.87

Return  on  net  assets  employed

-28.41

-2.16

-27.81

-21.23

-22.94

84.15

-27.26

-307

-6.69

Sales  /  net  working  capital

-

-

-

-

-

-

-

-

-

Stock  turnover  ratio

-

-

-

-

-

-

-

-

-

Creditor  days

-

-

-

-

-

-

-

-

-

Debtor  days

-

-

-

-

-

-

-

-

-

SHORT  TERM  STABILITY

 

 

 

 

 

 

 

 

 

Current  ratio

0.05

-37.50

0.08

-52.94

0.17

112

0.08

-27.27

0.11

Liquidity  ratio  /  acid  ratio

0.05

-37.50

0.08

-52.94

0.17

112

0.08

-27.27

0.11

Current  debt  ratio

0.62

16.98

0.53

20.45

0.44

51.72

0.29

107

0.14

Liquidity  ratio  reprocessed

-

-

-

-

-

-

-

-

-

Cashflow

318

126

-252

62.45

-404

22.95

-1,758

-247

1,194

Net  worth

7,806

-22.13

10,024

-21.76

12,812

-18.66

15,751

-21.42

20,045

LONG  TERM  STABILITY

 

 

 

 

 

 

 

 

 

Gearing

-

-

-

-

-

-

-

-

-

Equity  in  percentage

61.74

-5.41

65.27

-6.03

69.46

-10.26

77.40

-11.76

87.72

Total  debt  ratio

0.62

16.98

0.53

20.45

0.44

51.72

0.29

107

0.14

Working  capital

-4,593

93.54

-4,910

-5.42

-4,658

-9.48

-4,254

-70.44

-2,496

 

 

PROFIT  &  LOSS

 

 

 

 

 

 

 

 

 

 

Operating  Income

-

-

-

-

-

-

-

-

-

Turnover

-

-

-

-

-

-

-

-

-

Total  operating  expenses

-

-

-

-

-

-

-

-

-

Gross  Operating  Margin

1,245

98.96

626

-31.33

912

-25.60

1,225

-44.98

2,227

Operating  Charges

-

-

-

-

-

-

-

-

-

Employee  costs

-

-

-

-

-

-

-

-

-

Wages  and  salary

-

-

-

-

-

-

-

-

-

Employee  pension  costs

-

-

-

-

-

-

-

-

-

Social  security  contributions

-

-

-

-

-

-

-

-

-

Other  employee  costs

-

-

0

-

0

-

0

-

0

Director  remuneration

-

-

-

-

-

-

-

-

-

Amortization  and  depreciation

2,536

-0.02

2,536

0.02

2,536

0

2,536

0

2,536

Operating  result

-2,176

79.00

-2,755

94.62

-2,912

68.26

-4,266

-239

-1,258

Total  financial  income

-

-

-

-

-

-

-

-

-

Total  financial  expenses

42

22.24

34

23.73

27

-2.17

28

-66.40

84

Results  on  ordinary  operations  before  taxation

-2,218

79.55

-2,788

94.86

-2,939

68.45

-4,294

-220

-1,342

Extraordinary  Income

-

-

-

-

-

-

-

-

-

Extraordinary  Charges

-

-

-

-

-

-

-

-

-

Extraordinary  items

-

-

0

-

0

-

0

-

0

Results  for  the  Year  Before  Taxation

-2,218

79.55

-2,788

94.86

-2,939

68.45

-4,294

-220

-1,342

Other  appropriations

-

-

-

-

-

-

-

-

-

Taxation

-

-

-

-

-

-

-

-

-

Results  on  ordinary  operations  after  taxation

-2,218

79.55

-2,788

94.86

-2,939

68.45

-4,294

-220

-1,342

Net  result

-2,218

79.55

-2,788

94.86

-2,939

68.45

-4,294

-220

-1,342

Profit  (Loss)  for  the  Year  to  be  appropiated

-2,218

79.55

-2,788

94.86

-2,939

68.45

-4,294

-220

-1,342

Dividends

-

-

-

-

-

-

-

-

-

 

 

Industry comparison

 

Activity  code

21100

Activity  description

Manufacturer of basic pharmaceutical products.

 

 

Industry comparison

 

Activity  code

21100

Activity  description

Manufacturer of basic pharmaceutical products.

Industry  average  payment

expectation  days

55.53

Industry  average  day  sales outstanding

94.13

 

 

INDUSTRY QUARTILE ANALYSIS

 

Payment  Expectations

 

Company  result

--

Lower

73.04

Median

43.86

Upper

20.21

 

 

Day Sales Outstanding

 

Company  result

--

Lower

119.97

Median

65.52

Upper

22.86

 

 

Shareholder Details

 

Group Structure

No group structure for this company.

 

Minority Shareholders

No minority shareholders found

 

Minority Interests

No minority interests found

 

Companies that match this address

No Companies Match this address

 

Summons

There is no data for this company

 

Protested Bills

There is no data for this company

 

Bankruptcy and other legal events

There is no data for this company

 

Director details

 

CURRENT DIRECTOR DETAILS

 

Position

Managing  Director

Start  Date

01/11/2007

Street

9 PAALSESTEENWEG  HASSELT

Post  code

3500

Country

The  Netherlands

 

 

Name

Jeannine  Vanheers

Position

Director

Start  Date

27/07/2012

Street

9 PAALSESTEENWEG  HASSELT

Post  code

3500

Country

The  Netherlands

 

 

Position

Permanent  representative  legal  entity

Start  Date

27/07/2012

Street

9 PAALSESTEENWEG  HASSELT

Post  code

3500

Country

The  Netherlands

 

 

Name

AMAREX  NV

Position

Director

Start  Date

27/07/2012

 

 

CURRENT MANDATES  IN  OTHER  COMPANIES

 

Name

AMAREX  NV

Business  number

438001817

Position

Director

Start  Date

27/07/2012

Business  number

438001817

Position

Permanent  representative  legal  entity

Start  Date

27/07/2012

 

 

FORMER  DIRECTOR  DETAILS

 

Name

Els  Wassink

Position

Director

Start  Date

01/11/2007

End  Date

27/07/2012

Street

209 ZAVELVENNESTRAAT  HASSELT

Post  code

3500

Country

Belgium

 

 

Name

Ann  Wassink

Position

Director

Start  Date

01/11/2007

End  Date

27/07/2012

Street

544 KEMPISCHESTEENWEG  HASSELT

Post  code

3500

Country

Belgium


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.66.34

UK Pound

1

Rs.100.03

Euro

1

Rs.71.45

 

 

INFORMATION DETAILS

 

Analysis Done by :

KAS

 

 

Report Prepared by :

TPT

 

               

RATING EXPLANATIONS

 

RATING

STATUS

PROPOSED CREDIT LINE

 

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

 

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

 

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

 

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

 

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

 

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

 

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

Credit not recommended

 

--

NB

New Business

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.